NCT05163405
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
NCT02195479
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- California City, California, United States
- Corona, California, United States
- Fountain Valley, California, United States
- Los Angeles, California, United States
NCT03951220
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Churchill Hospital Oxford, Oxfordshire, United Kingdom
NCT03828292
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Shibuya-Ku, Tokyo, Japan
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Okayama, Japan
- GSK Investigational Site Tokyo, Japan
NCT04260217
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- City of Hope Duarte, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Mayo Clinic Jacksonville, Florida, United States
- Weill Cornell Univ Hospitals New York, United States
NCT05835726
- Conditions
- Autologous Stem Cell Transplantation, Blood Protein Disorders, Cardiovascular Diseases, +15 more
- Locations
-
- Fondazione Policlinico Universitario A.Gemelli IRCCS Rome, Italy
Completed
Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma
NCT04248244
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
NCT02916771
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT07102706
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT01711671
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Emory University Hospital Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States